Category: Airway Management
Keywords: prothrombin complex concentrate, warfarin, bleeding (PubMed Search)
For patients with bleeding due to warfarin, prothrombin complex concentrate (PCC) is the recommended antidote. Historically, PCC has been dosed on weight and INR:
· INR 2 - 4: 25 units/kg, max 2500 units
· INR 4 - 6: 35 units/kg, max 3500 units
· INR > 6: 50 units/kg, max 5000 units
New data demonstrates that fixed dosing offers several advantages with similar efficacy outcomes:
· Standardized dosing
· Improved time to administration
· Decreased cost
The University of Maryland Health System has adopted a fixed dose strategy for all patients with warfarin-associated critical bleeding:
· Bleeding site other than intracranial hemorrhage AND INR 1.4 - 6 AND weight ≤ 100 kg = 1500 units
· Intracranial hemorrhage OR > 100 kg OR INR >6 = 2000 units
**Note: PCC is also the antidote of choice for reversing critical bleeding due to factor Xa inhibitors (rivaroxaban, apixaban, edoxaban). All critical bleeds due to these agents should receive 50 units/kg, max 5000 units.
Klein L, Peters J, Miner J, Gorlin J. Evaluation of fixed dose 4-factor prothrombin complex concentrate for emergent warfarin reversal. Am J Emerg Med. 2015;33: 1213-12128.
Astrup G, Sarangarm P, Burnett A. Fixed dose 4-factor prothrombin complex concentrate for the emergent reversal of warfarin: a retrospective analysis. J Thrombosis Thrombolysis. 2018;45:300-305.
Scott R, Kersten B, Baisor J, Nadler M. Evaluation of fixed-dose four-factor prothrombin complex concentrate for emergent warfarin reversal in patients with intracranial hemorrhage. J Emerg Med. 2018;54(6):861-866.